SM
NDRM

Sabby Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Sabby Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-23,033
Closed -$511K – 369
2016
Q4 		$511K Buy
+23,033
New +$431K 0.03% 196
2015
Q4 		– Sell
-12,416
Closed -$242K – 430
2015
Q3 		$257K Buy
+12,416
New +$255K 0.01% 334

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Sabby Management's NDRM Position: Q1 2017 in Review

Sabby Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q1 2017, closing a stake of 23,033 shares — an estimated $511K sold.

Sabby Management first reported a position in NDRM in Q3 2015 and held it in 2 quarters. The position peaked at $511K in Q4 2016. 70 funds tracked by Wall St. Rank hold NDRM as of Q1 2017.

  • Sabby Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q1 2017 after selling out during the quarter.
  • Sabby Management sold 23,033 NeuroDerm Ltd. Ordinary Shares shares in Q1 2017, an estimated $511K.
  • Sabby Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 2 quarters.
  • Sabby Management's NeuroDerm Ltd. Ordinary Shares position peaked at $511K in Q4 2016.
  • 70 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q1 2017.

Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.